Andrew West, PhD, is a tenured professor in the Department of Pharmacology and Cancer Biology at Duke University with secondary appointments in neurology and neurobiology. Dr. West received his graduate and post-doctoral training at the Mayo Clinic, University of California, Los Angeles and Johns Hopkins Udall Centers of Parkinson’s Disease Research Excellence. Dr. West studies novel pathways and targets in neurodegenerative diseases with the goal of translating discoveries to successful neuroprotective treatment strategies in the clinic. Most of the West laboratory’s efforts focus on the LRRK2 protein as a therapeutic target, biomarker and a window into new mechanisms involved in neurodegeneration that causes Parkinson’s disease.